{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:39:58Z","timestamp":1771925998329,"version":"3.50.1"},"reference-count":32,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2009,5,6]],"date-time":"2009-05-06T00:00:00Z","timestamp":1241568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:p><jats:bold>Objectives\n\t\t\t\t\t<\/jats:bold> The aim of the study was to describe trends and risk factors for mortality and changes in antibiotic resistance, serotypes and clones among HIV\u2010infected patients with invasive pneumococcal disease (IPD).<\/jats:p><jats:p><jats:bold>Methods\n\t\t\t\t\t<\/jats:bold> A prospective study of 199 episodes of IPD occurring in a cohort of 4011 HIV\u2010infected patients was carried out. Predictors of mortality included clinical and microbiological data. The 7\u2010valent pneumococcal conjugate vaccine (PCV7) for children was introduced in late 2001. Time periods were classified for mortality studies as pre\u2010 (1986\u20131996), early (1997\u20132001) and late (2002\u20132007) highly active antiretroviral therapy (HAART) era, and for serotype studies as pre\u2010PCV7 (1986\u20132001) and PCV7 (2002\u20132007) era.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> Of 199 IPD episodes, 71 (36%) occurred in HIV\u2010infected patients with associated comorbidities (mainly liver cirrhosis; 52 of 71), which increased in recent years. The incidence of IPD decreased from the pre\u2010HAART era to the early HAART era and then remained stable in the late HAART era (24.1, 8.4 and 7.4 episodes per 1000 patient\u2010years, respectively). Rates of 30\u2010day mortality have risen over the three periods (8, 19 and 25%, respectively; <jats:italic>P<\/jats:italic>=0.017). In multiple logistic regression analysis, predictors of mortality were shock at presentation [odds ratio (OR) 7.01; 95% confidence interval (CI) 2.05\u201323.87] and associated comorbidities (OR 4.27; 95% CI 1.53\u201311.92). In the PCV7 era, IPD caused by non\u2010PCV7 serotypes increased, and resistance to betalactams decreased. The most frequent genotypes were Spain<jats:sup>9V<\/jats:sup>\u2010ST156, Spain<jats:sup>23F<\/jats:sup>\u2010ST81, ST88<jats:sup>19F<\/jats:sup>, Sweden<jats:sup>1<\/jats:sup>\u2010ST304 and Spain<jats:sup>6B<\/jats:sup>\u2010ST90.<\/jats:p><jats:p><jats:bold>Conclusions\n\t\t\t\t\t<\/jats:bold> In the late HAART era, the incidence of IPD has not significantly decreased. Mortality from IPD has risen in association with an increase in comorbidities such as liver cirrhosis. New vaccination strategies are needed to diminish the burden of IPD in the HIV\u2010infected population.<\/jats:p>","DOI":"10.1111\/j.1468-1293.2009.00717.x","type":"journal-article","created":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T02:43:57Z","timestamp":1241664237000},"page":"488-495","source":"Crossref","is-referenced-by-count":32,"title":["Trends in mortality and antibiotic resistance among HIV\u2010infected patients with invasive pneumococcal disease"],"prefix":"10.1111","volume":"10","author":[{"given":"I","family":"Grau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Ardanuy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Li\u00f1ares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Podzamczer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MH","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Pallares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,2]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"22","article-title":"Decline in the AIDS and death rates in the EuroSIDA Study","volume":"362","author":"Mocroft A","year":"2003","journal-title":"an observational study"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-132-3-200002010-00003"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2008.00546.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/430356"},{"key":"e_1_2_6_6_2","first-page":"609","article-title":"Bacterial pneumonia in HIV\u2010infected patients","volume":"9","author":"Curran A","year":"2008","journal-title":"use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-1-200601030-00004"},{"key":"e_1_2_6_8_2","first-page":"437","article-title":"Invasive pneumococcal disease in a cohort of HIV\u2010infected adults","volume":"20","author":"Barry PM","year":"2006","journal-title":"incidence and risk factors, 1990\u20132003"},{"key":"e_1_2_6_9_2","first-page":"1623","article-title":"Invasive pneumococcal disease in patients infected with HIV","volume":"38","author":"Jordano Q","year":"2004","journal-title":"still a threat in the era of highly active antiretroviral therapy"},{"key":"e_1_2_6_10_2","first-page":"1345","article-title":"Hospitalization for pneumonia among individuals with and without HIV infection, 1995\u20132007","volume":"47","author":"Sogaard OS","year":"2008","journal-title":"a Danish population-based, nationwide cohort study"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.13.1533"},{"key":"e_1_2_6_12_2","volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard: 7th edition. CLSI Document M7\u2010A6","author":"Clinical and Laboratory Standard Institute (CLSI).","year":"2006"},{"key":"e_1_2_6_13_2","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing; 18th Informational Supplement. CLSI Document M100\u2010S18","author":"Clinical Laboratory Standard Institute (CLSI).","year":"2008"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.7.2565-2571.2001"},{"key":"e_1_2_6_15_2","first-page":"3049","article-title":"A multilocus sequence typing scheme for Streptococcus pneumoniae","volume":"144","author":"Enright MC","year":"1998","journal-title":"identification of clones associated with serious invasive disease"},{"key":"e_1_2_6_16_2","first-page":"867","article-title":"Invasive pneumococcal disease among children in a health district of Barcelona","volume":"12","author":"Calbo E","year":"2006","journal-title":"early impact of pneumococcal conjugate vaccine"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1086\/524660"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.1.49"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508243330802"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.152.9.1808"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(04)01060-6"},{"key":"e_1_2_6_22_2","first-page":"125","article-title":"Bacteraemic pneumococcal pneumonia","volume":"55","author":"Feldman C","year":"2007","journal-title":"impact of HIV on clinical presentation and outcome"},{"key":"e_1_2_6_23_2","first-page":"27","article-title":"HIV Outpatient Study Investigators. Mortality in the highly active antiretroviral therapy era","volume":"43","author":"Palella FJ","year":"2006","journal-title":"changing causes of death and disease in the HIV Outpatient Study"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030218"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199815000-00001"},{"key":"e_1_2_6_26_2","first-page":"41","article-title":"Trends in the incidence of cancers among HIV\u2010infected persons and the impact of antiretroviral therapy","volume":"23","author":"Crum\u2010Cianflone N","year":"2009","journal-title":"a 20-year cohort study"},{"key":"e_1_2_6_27_2","first-page":"165","article-title":"Liver cirrhosis in HIV\u2010infected patients","volume":"15","author":"Castellares C","year":"2008","journal-title":"prevalence, aetiology and clinical outcome"},{"key":"e_1_2_6_28_2","first-page":"1507","article-title":"Hepatitis C virus coinfection increases mortality in HIV\u2010infected patients in the highly active antiretroviral therapy era","volume":"39","author":"Anderson KB","year":"2004","journal-title":"data from the HIV Atlanta VA Cohort Study"},{"key":"e_1_2_6_29_2","first-page":"46","article-title":"Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults","volume":"45","author":"Alanee SR","year":"2007","journal-title":"an international study"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.16.2043"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1086\/592972"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1086\/594125"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0705589104"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2009.00717.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2009.00717.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T16:19:48Z","timestamp":1696868388000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2009.00717.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,2]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1468-1293.2009.00717.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2009.00717.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,2]]}}}